Statistics for Myeloablative temozolomide enhances CD8⁺ T-cell responses to vaccine and is required for efficacy against brain tumors in mice.

Total visits

views
Myeloablative temozolomide enhances CD8⁺ T-cell responses to vaccine and is required for efficacy against brain tumors in mice. 128

Total visits per month

views
October 2024 0
November 2024 0
December 2024 0
January 2025 1
February 2025 0
March 2025 0
April 2025 0

File Visits

views
Myeloablative temozolomide enhances CD8⁺ T-cell responses to vaccine and is required for efficacy against brain tumors in mice.pdf 88

Top country views

views
United Kingdom 18
Germany 13
United States 8
Singapore 3
China 2
South Korea 2
France 1

Top city views

views
Changi 3
Ashburn 2
Seoul 2
Beijing 1
Kiez 1
Nanjing 1
Old Bridge 1
Yulee 1